2015 Q1 Form 10-Q Financial Statement

#000109181815000024 Filed on February 23, 2015

View on sec.gov

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2825	USD
CY2014Q4	us-gaap	Liabilities Liabilities	919421	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1735	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1041	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	11115	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	16094	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12605	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8656	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2131812230	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2124900908	shares
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2131812230	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2124900908	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-894660	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	-871558	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24761	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27255	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	21318	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	21249	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11260834	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11208314	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12176839	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12101150	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1735	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2825	USD
CY2014Q4	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	4234	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2505	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	27255	USD
CY2014Q4	us-gaap	Revenues Revenues	72076	USD
CY2013Q4	us-gaap	Revenues Revenues	53451	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	91300	USD
CY2014Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15005	USD
CY2013Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8262	USD
CY2014Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	76295	USD
CY2013Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114469	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	34566	USD
CY2013Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2080095492	shares
CY2013Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	898813	USD
CY2014Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13540	USD
CY2014Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		USD
CY2014Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	180738	USD
CY2014Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	180738	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	917686	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	895988	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	298001	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	285950	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19328	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31295	USD
CY2014Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	14664	USD
CY2014Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	10430	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	24761	USD
CY2014Q4	us-gaap	Assets Assets	24761	USD
CY2014Q3	us-gaap	Assets Assets	27255	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	391415	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	387575	USD
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	37510	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	23057	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	30394	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-75689	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-111052	USD
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00004
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0001
CY2014Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2127534360	shares
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-56734	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-92337	USD
CY2014Q4	us-gaap	Interest Expense InterestExpense	18955	USD
CY2013Q4	us-gaap	Interest Expense InterestExpense	18715	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18955	USD
CY2013Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18715	USD
CY2013Q4	us-gaap	Operating Expenses OperatingExpenses	122731	USD
CY2014Q4	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims		USD
CY2013Q4	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims	10000	USD
CY2014Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		USD
CY2013Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22404	USD
CY2014Q4	us-gaap	Interest Paid InterestPaid	2670	USD
CY2013Q4	us-gaap	Interest Paid InterestPaid		USD
CY2014Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1464	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	21807	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11188	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32995	USD
CY2014Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	USD
CY2013Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	300000	USD
CY2014Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	38000	USD
CY2013Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	63000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	150000	USD
CY2014Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13057	USD
CY2013Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11281	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-64464	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-128193	USD
CY2014Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
CY2014Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3840	USD
CY2013Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-84422	USD
CY2014Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	12121	USD
CY2013Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	23785	USD
CY2013Q4	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	6500	USD
CY2014Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4979	USD
CY2013Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11244	USD
CY2014Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3057	USD
CY2013Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
CY2014Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3949	USD
CY2013Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-27117	USD
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2012Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	3000	pure
CY2012Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2014Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2014Q4	clri	Receivables Factoring Discount Rate Lower Range ReceivablesFactoringDiscountRateLowerRange	0.0225	pure
CY2014Q4	clri	Receivables Factoring Discount Rate Higher Range ReceivablesFactoringDiscountRateHigherRange	0.0625	pure
CY2014Q4	us-gaap	Concentration Risk Credit Risk Uninsured Deposits ConcentrationRiskCreditRiskUninsuredDeposits	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="line-height: 14pt; margin: 0pt; text-indent: 63.7pt; font-size: 12pt; font-family: 'times new roman';" align="justify"><b>CONCENTRATION OF CREDIT RISK</b></p> <p style="line-height: 14pt; margin: 0pt; padding-left: 63.7pt; font-size: 12pt; font-family: 'times new roman';" align="justify">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in noninterest-bearing transaction accounts are insured up to a maximum of $<font>250,000</font> at all FDIC-insured institutions.</p> </div>
CY2014Q4	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2014Q4	us-gaap	Advertising Expense AdvertisingExpense	1841	USD
CY2013Q4	us-gaap	Advertising Expense AdvertisingExpense	2005	USD
CY2014Q4	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="line-height: 14pt; margin: 0pt; padding-left: 63.35pt; font-size: 12pt; font-family: 'times new roman';" align="justify"><b>USE OF ESTIMATES</b></p> <p style="line-height: 14pt; margin: 0pt; padding-left: 63.7pt; font-size: 12pt; font-family: 'times new roman';" align="justify">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</p> </div>
CY2014Q4	clri	Debt Instrument Convertible Number Of Convertible Notes DebtInstrumentConvertibleNumberOfConvertibleNotes	1	item
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	38000	USD
CY2013Q4	clri	Debt Instrument Convertible Number Of Convertible Notes DebtInstrumentConvertibleNumberOfConvertibleNotes		item
CY2014Q4	dei	Entity Registrant Name EntityRegistrantName	Cleartronic, Inc.
CY2014Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2014Q4	dei	Document Type DocumentType	10-Q
CY2014Q4	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014Q4	dei	Amendment Flag AmendmentFlag	false
CY2014Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2014Q4	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2135562230	shares
CY2014Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2014Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1

Files In Submission

Name	View Source	Status
0001091818-15-000024-index-headers.html	Edgar Link	pending
0001091818-15-000024-index.html	Edgar Link	pending
0001091818-15-000024.txt	Edgar Link	pending
0001091818-15-000024-xbrl.zip	Edgar Link	pending
clri-20141231.xml	Edgar Link	completed
clri-20141231.xsd	Edgar Link	pending
clri-20141231_cal.xml	Edgar Link	unprocessable
clri-20141231_def.xml	Edgar Link	unprocessable
clri-20141231_lab.xml	Edgar Link	unprocessable
clri-20141231_pre.xml	Edgar Link	unprocessable
clri0219201510q.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending